Us Bancorp \De\ Cytokinetics Inc Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Cytokinetics Inc stock. As of the latest transaction made, Us Bancorp \De\ holds 5,290 shares of CYTK stock, worth $258,522. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,290

Previous 7,042 24.88%

Holding current value

$258,522

Previous $381,000 26.77%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$51.22 - $60.16 $89,737 - $105,400	-1,752 Reduced 24.88%	5,290 $279,000
Q2 2024 Aug 06, 2024	BUY	$47.86 - $75.05 $67,386 - $105,670	1,408 Added 24.99%	7,042 $381,000
Q1 2024 May 07, 2024	BUY	$63.75 - $108.06 $144,393 - $244,755	2,265 Added 67.23%	5,634 $394,000
Q4 2023 Feb 09, 2024	SELL	$26.88 - $83.49 $258,074 - $801,587	-9,601 Reduced 74.02%	3,369 $281,000
Q3 2023 Nov 03, 2023	SELL	$29.46 - $36.61 $134,573 - $167,234	-4,568 Reduced 26.05%	12,970 $382,000
Q2 2023 Aug 09, 2023	SELL	$32.62 - $40.75 $48,995 - $61,206	-1,502 Reduced 7.89%	17,538 $572,000
Q1 2023 May 09, 2023	SELL	$33.36 - $45.71 $20,282 - $27,791	-608 Reduced 3.09%	19,040 $670,000
Q4 2022 Feb 13, 2023	SELL	$35.77 - $51.11 $18,707 - $26,730	-523 Reduced 2.59%	19,648 $900,000
Q3 2022 Oct 27, 2022	SELL	$38.54 - $54.52 $197,324 - $279,142	-5,120 Reduced 20.24%	20,171 $977,000
Q2 2022 Aug 01, 2022	BUY	$33.93 - $48.92 $212,876 - $306,924	6,274 Added 32.99%	25,291 $994,000
Q1 2022 May 11, 2022	SELL	$29.74 - $46.0 $4,907 - $7,590	-165 Reduced 0.86%	19,017 $700,000
Q4 2021 Feb 11, 2022	SELL	$34.35 - $46.38 $5,805 - $7,838	-169 Reduced 0.87%	19,182 $874,000
Q3 2021 Nov 10, 2021	BUY	$18.54 - $35.74 $327,490 - $631,311	17,664 Added 1047.07%	19,351 $692,000
Q2 2021 Aug 05, 2021	BUY	$19.79 - $26.99 $19,750 - $26,936	998 Added 144.85%	1,687 $33,000
Q4 2020 Feb 04, 2021	BUY	$15.26 - $28.61 $3,677 - $6,895	241 Added 53.79%	689 $14,000
Q3 2020 Nov 10, 2020	BUY	$20.58 - $28.96 $5,309 - $7,471	258 Added 135.79%	448 $10,000
Q4 2018 Feb 13, 2019	BUY	$5.91 - $9.29 $271 - $427	46 Added 31.94%	190 $1,000
Q3 2018 Nov 01, 2018	BUY	$6.4 - $9.85 $921 - $1,418	144 New	144 $1,000
Q4 2017 Feb 02, 2018	SELL	$7.25 - $15.65 $536 - $1,158	-74 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$12.0 - $15.0 $888 - $1,110	74	74 $1,000

Others Institutions Holding CYTK

# of Institutions

409

Shares Held

125M

Call Options Held

4.6M

Put Options Held

2.43M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.6B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account